CSF3 and graft versus host disease: Moreover, although additional studies are required, we can speculate the potential generalizability of these findings onto other prophylactic regimens in GVHD (i.e., anti-thymocyte globulin, G-CSF, etc.)at ameliorating GVHD resulting from shared immune mechanisms across different tissues [40].